| Previous Close | 3.10 |
| Open | 3.10 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 3.05 - 3.10 |
| 52 Week Range | 1.90 - 3.88 |
| Volume | 19,227 |
| Avg. Volume | 33,936 |
| Market Cap | 240.28M |
| Beta | 0.85 |
| PE Ratio (TTM) | -5.10 |
| EPS (TTM) | -0.6 |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.00 |
Capital Cube•2 months agoSIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017
Categories: Yahoo FinanceGet free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc. and Newlink Genetics Corporation (ACHN-US, ... Read more (Read more...)
- GlobeNewswire•3 months ago
SIGA to Present at the Jefferies Global Healthcare Conference on June 9, 2017
NEW YORK, May 31, 2017-- SIGA Technologies, Inc., a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced that Dr. Phillip ...
Capital Cube•5 months agoSIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
Categories: Yahoo Finance Get free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc., Newlink Genetics Corporation and NanoViricides, ... Read more (Read more...)
